Abstracts - faqs.org

Abstracts

Zoology and wildlife conservation

Search abstracts:
Abstracts » Zoology and wildlife conservation

Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-beta in cells lacking the CDK indicator p15

Article Abstract:

Recent research into the regulation of the activity of the cyclin-dependent kinases (CDKs) which control cell growth and division has found that the cytokine TGF-beta can lead to the inhibition of Cdk4 and Cdk6 by boosting their level of tyrosine phosphorylation. The ability of TGF-beta to prevent expression of the CDK tyrosine phosphatase Cdc25A leads to tyrosine phosphorylation and inactivation of Cdk4/6 in a human mammary epithelial cell line. Defects in TGF-beta antiproliferative responsiveness may result from a rise in Cdc25A activity, a factor which has been identified in breast cancer.

Author: Massague, Joan, Iavarone, Antonio
Publisher: Macmillan Publishing Ltd.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 1997
Enzyme inhibitors

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Crossing receptor boundaries

Article Abstract:

A receptor tyrosine kinase (Ret) is required for signaling by the glial-cell-line-derived neurotrophic factor (GDNF). The receptor-ligand binding involves the cell-surface membrane protein GDNF-alpha. Studies show that Ret expression induces GDNF binding. The binding of GDNF to Ret requires association of GDNF and GDNF-alpha, and Ret phosphorylation on tyrosine. The phenotypes of GDNF-deficient and Ret-deficient mice are similar. GDNF is a member of the transforming growth factor-beta family but its receptor is a tyrosine kinase rather than a serine/threonine kinase.

Author: Massague, Joan
Publisher: Macmillan Publishing Ltd.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 1996
Ligand binding (Biochemistry), Cell receptors

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways

Article Abstract:

DPC4 is important for the function of Smad1 and Smad2 in distinct transforming growth factor pathways, signaling mesoderm formation in Xenopus embryos. SMAD is a set of evolutionary conserved proteins. It is also essential for pathways signaling antimitogenic and transcriptional responses in mammalian breast epithelial cells. The SMAD signalling network may be disabled in cancer cells that have lost DPC4 functioning.

Author: Hata, Akiko, Lagna, Giorgio, Hemmati-Brivanlou, Ali, Massague, Joan
Publisher: Macmillan Publishing Ltd.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 1996
Physiological aspects, Observations, Mesoderm

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Research, Protein tyrosine kinase, Protein-tyrosine kinase, Proteins, Transforming growth factors
Similar abstracts:
  • Abstracts: Defective activation and survival of T cells lacking the Ets-1 transcription factor. Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene
  • Abstracts: Regulation of glutamate release by presynaptic kainate receptors in the hippocampus. Induction of LTP in the hippocampus needs synaptic activation of glutamate metabotropic receptors
  • Abstracts: Loss of cerebellar Purkinje cells in aged mice homozygous for a disrupted PrP gene. Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors
  • Abstracts: Role of the thrombin receptor in development and evidence for a second receptor. Thrombin signalling and protease-activated receptors
  • Abstracts: Cell-cycle control and its watchman. Creation of human tumour cells with defined genetic elements. A checkpoint on the road to cancer
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.